The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E- and P-selectin is differentially regulated

被引:81
作者
Borges, E [1 ]
Pendl, G [1 ]
Eytner, R [1 ]
Steegmaier, M [1 ]
Zollner, O [1 ]
Vestweber, D [1 ]
机构
[1] UNIV MUNSTER,INST CELL BIOL,ZMBE,D-48149 MUNSTER,GERMANY
关键词
D O I
10.1074/jbc.272.45.28786
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HECA452 carbohydrate epitope, also termed cutaneous lymphocyte antigen, is known to bind to E-selectin and defines a human T cell subset preferentially found in inflamed skin, Activated T cells can express a functional form of the P-selectin glycoprotein ligand-l (PSGL-1), the major ligand known for P-selectin. Here we show that PSGL-1 can exist in two forms, of which only one carries the HECA452 epitope and binds to E-selectin, while the other only binds to P-selectin, We have analyzed the glycoprotein ligands for E- and P-selectin on the mouse CD8(+) T cell clone 4G3 at 4, 8, and 12 days after antigen-specific activation, Only at day 4 did the cells bind to E-selectin, whereas cells at all three activation stages bound to P-selectin, Expression of the HECA452 epitope correlated with E-selectin binding, In affinity isolation experiments, PSGL-1 was isolated as the major ligand by E-selectin-IgG and by P-selectin-IgG; however, PSGL-1 only bound to E-selectin at day 4, whereas it bound to P-selectin at all three activation stages, Immunoprecipitated PSGL-1 from cells at day 4, but not from cells at days 8 and 12, was recognized in immunoblots by monoclonal antibody HECA452. In immunoblots of total extracts of cells at day 4, HECA452 recognized a 240/140-kDa pair of protein bands as the major antigen, These bands could be completely removed by depletion of cell extracts with anti-PSGL-1 antibodies, Our data suggest that the carbohydrate requirements for binding of PSGL-1 to P-selectin differ from those necessary for binding to E-selectin. Furthermore, we conclude that the major glycoprotein carrier for the HECA452 epitope on activated 463 cells is PSGL-1.
引用
收藏
页码:28786 / 28792
页数:7
相关论文
共 44 条
[1]   DISTINCT CELL-SURFACE LIGANDS MEDIATE T-LYMPHOCYTE ATTACHMENT AND ROLLING ON P-SELECTIN AND E-SELECTIN UNDER PHYSIOLOGICAL FLOW [J].
ALON, R ;
ROSSITER, H ;
WANG, XH ;
SPRINGER, TA ;
KUPPER, TS .
JOURNAL OF CELL BIOLOGY, 1994, 127 (05) :1485-1495
[2]   P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues [J].
Austrup, F ;
Vestweber, D ;
Borges, E ;
Lohning, M ;
Brauer, R ;
Herz, U ;
Renz, H ;
Hallmann, R ;
Scheffold, A ;
Radbruch, A ;
Hamann, A .
NATURE, 1997, 385 (6611) :81-83
[3]   THE CUTANEOUS LYMPHOCYTE ANTIGEN IS A SKIN LYMPHOCYTE HOMING RECEPTOR FOR THE VASCULAR LECTIN ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULE-1 [J].
BERG, EL ;
YOSHINO, T ;
ROTT, LS ;
ROBINSON, MK ;
WARNOCK, RA ;
KISHIMOTO, TK ;
PICKER, LJ ;
BUTCHER, EC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1461-1466
[4]   EFFICACY OF SYNTHETIC VACCINES IN THE INDUCTION OF CYTOTOXIC T-LYMPHOCYTES - COMPARISON OF THE COSTIMULATING SUPPORT PROVIDED BY HELPER T-CELLS AND LIPOAMINO ACID [J].
BORGES, E ;
WIESMULLER, KH ;
JUNG, G ;
WALDEN, P .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 173 (02) :253-263
[5]   P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin [J].
Borges, E ;
Tietz, W ;
Steegmaier, M ;
Moll, T ;
Hallmann, R ;
Hamann, A ;
Vestweber, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :573-578
[6]   The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum [J].
Borges, E ;
Eytner, R ;
Moll, T ;
Steegmaier, M ;
Campbell, MA ;
Ley, K ;
Mossmann, H ;
Vestweber, D .
BLOOD, 1997, 90 (05) :1934-1942
[7]   GMP-140 (P-SELECTIN/CD62) BINDS TO CHRONICALLY STIMULATED BUT NOT RESTING CD4+ LYMPHOCYTE-T AND REGULATES THEIR PRODUCTION OF PROINFLAMMATORY CYTOKINES [J].
DAMLE, NK ;
KLUSSMAN, K ;
DIETSCH, MT ;
MOHAGHEGHPOUR, N ;
ARUFFO, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (07) :1789-1793
[8]  
DEBOER OJ, 1994, IMMUNOLOGY, V81, P359
[9]  
DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147
[10]  
FUKUSHIMA K, 1984, CANCER RES, V44, P5279